Gene Biotherapeutics Inc.
PrivateLast Round
Series B
May 22, 2020
Est. Valuation
$20M
Total Funding Raised
$10.25M
Company Overview
Gene Biotherapeutics Inc. operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series B round in May 2020.
Gene Biotherapeutics Inc. is a clinical-stage biotechnology company that develops and commercializes DNA-based biotherapeutics for the treatment of cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gene Biotherapeutics Inc. Comparables
Compare Gene Biotherapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| XyloCor Therapeutics | 91% | |
| Renova Therapeutics | 81% | |
| AnGes, Inc. | 65% |
For institutional investors. Book with your work email.
Gene Biotherapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 22, 2020 | ||||
| Series A | Jun 7, 2016 | ||||
| Strategic | Mar 3, 2014 | ||||
| Series A | Apr 4, 2013 | ||||
| Private Placement | Feb 16, 2012 | ||||
Private Placement | Oct 15, 2009 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 22, 2020
$1.7M round led by Nostrum Pharmaceuticals, LLC
- Jun 7, 2016
$3M round raised
For institutional investors. Book with your work email.
Gene Biotherapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gene Biotherapeutics Inc.'s valuation, stock price, and market status.
Is Gene Biotherapeutics Inc. a public or private company?
Gene Biotherapeutics Inc. is a private company.
What is the current stock price of Gene Biotherapeutics Inc.?
Gene Biotherapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Gene Biotherapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gene Biotherapeutics Inc. worth (valuation)?
Gene Biotherapeutics Inc.'s valuation is estimated at $20.0M based on funding round data.
Can I buy Gene Biotherapeutics Inc. stock?
Gene Biotherapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gene Biotherapeutics Inc.'s last funding round?
Gene Biotherapeutics Inc.'s most recent funding round was Series B on May 22, 2020.
Who are the main investors in Gene Biotherapeutics Inc.?
Investor information for Gene Biotherapeutics Inc. is not publicly disclosed.
Will Gene Biotherapeutics Inc. IPO soon?
No public IPO plans have been announced for Gene Biotherapeutics Inc..
How can I track Gene Biotherapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Gene Biotherapeutics Inc.'s shares on secondary markets.